Previously, Kitamura et al. [25] found that esophageal cancer patients with high Ki-67 index obtained significantly higher efficacy rate than patients with low Ki-67 index (73.9% versus 38.5%, P = 0.0013) after receiving neoadjuvant chemoradiotherapy. This evidence concerns the gene MKI67 and esophageal cancer.